Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 4c

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q2 EPS of ($0.19), $0.04 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Aon names interim CFO as Edmund Reese exits the firm